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Abstract: Pharmacokinetics of oxytetracycline were investigated in 20 sheep following intravenous injection of 40, 80 and 160
mg/kg doses. An increase in concentration of oxytetracycline was found with increasing dose at all the sampling times in each animal.
The peak plasma concentration of oxytetracycline attained after intravenous administration of 40, 80 and 160 mg/kg of the drug
was 18.67±0.09, 40.63±0.16 and 86.51±0.10 µg/ml, respectively. These plasma concentrations decreased with plasma half lives
of 10.88 ± 0.29, 5.87 ± 0.08 and 7.35 ± 0.08 hours respectively. Oxytetracycyine resided, as indicated by MRT for 11.23±0.25,
5.78±0.08, 6.73±0.05 hours post dosing of 40, 80 and 160 µg/kg body weight of drug. After administration of the drug the Clt
was observed to be 8.71±0.08, 9.73±0.06 and 9.74±0.03 ml/h. The Vd in the present study was concluded to be 8.19±0.2,
5.09±0.16 and 6.22±0.06 liters after three exponential doses. It was, therefore, concluded that the plasma concentration of
oxytetracycline is dose related according to the present investigation.

Koyunlarda Çeşitli Damariçi Dozlarından Sonra Oksitetrasiklin’in Pharmakokinetiği
Özet: Oksitetrasiklin’in farmakokinetiği 20 koyun üzerinde araştırıldı. Araştırmada koyunlara, 40, 80 ve 160 mg/kg’lık
oksitetrasiklin, damardan enjekte edildi. Her örnek alımda, artan dozlarla birlikte, hayvanların hepsinde oksitetrasiklin
konsantrasyonunun yükseldiği gözlendi. 40, 80 ve 160 mg/kg’lik damariçi ulaç uygulamasından sonra, oksitetrasiklinin plazma
konsantrasyonlarındaki en yüksek değerleri sırasıyla 18.67 ± 0.09, 40.63 + 0.16 ve 86.51 ± 0.10 µg/ml oldu. Bu plazma
konsantrasiyonları sırasıyla 10.88 ± 0.29, 5.87 ± 0.08 ve 7.35 ± 0.08 saatlik yarılanma süreleriyle azalmıştır. MRT değerlerine
göre oksitetrasiklin 40, 80 ve 160 mg/kg’lık dozlardan sonra 11.23 ± 0.25, 5.78 ± 0.08 ve 6.73 ± 0.05 saat koyunlarda kalmıştır.
İlacın verilmesinden sonra Clt’nin 8.71 ± 0.08, 9.73 ± 0.06 ve 9.74 ± 0.03 ml/saat olduğu bulunmuştur. Bu çalışmada üç üstel
dozdan sora Vd’nin 8.19 ± 0.2, 5.09 ± 0.16 ve 6.22 + 0.06 litre olduğu sonucuna varıldı. Böylece oksitetrasiklinin plazma
konsantrasyonunun doza bağlı olduğu sonucuna varıldı.

Introduction
Oxytetracycline is a broad spectrum antibiotic which
has been used widely in human and veterinary practice
(1). The disposition of oxytetracycline is reported to be
influenced by dosage form, route of administration,
absorption characteristics, diseased states and age of the
animals (2). Research in the local environment on
imported drugs is important because most of the work on
these drugs is carried out in the countries where the
genetic make up of humans and animals, environmental
conditions and nutritional status are different from local

ones. These variations may affect the disposition kinetics
and dosage requirements of drugs (3) thus, warranting
the determination of bioavailability and pharmacokinetics
of drugs particularly those with low therapeutic indices.
Unfortunately, much of this class of specific information
is not readily available for clinical application in veterinary
medicine. The present subject was, therefore, designed to
study the pharmacokinetics of injectable veterinary
formulation of oxytetracycline in various dosage regimens
in normal sheep.
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Materials and Methods
Drug Administration
After withdrawing a control blood sample in each
experiment, oxytetracycline (Terramycin, pfizer Lab.
Limited, Karachi, Pakistan) was injected through venous
cannula at dosages of 40, 80 and 160 mg/kg body weight
in each animal.

Statistical Analysis
The pharmacokinetics and disporition parameters
determined in sheep for oxytetracycline were compared
to evaluate the difference between the two sources of the
drug. Mean value (X) and the standard error of mean
(±SEM) were calculated for each parameter using the
computer program SPSS (7).

Animals
The experiments were performed on 20 clinically
healthy female sheep weighing 15 to 20 kg. The animals
were put out to graze and green fodder was provided in
the afternoon while water was provided freely. The same
animals were used for the three doses of oxytetracycline,
given after a wash-out period of one week following each
experimentation.
Study Design
The pharmacokinetics of oxytetracycline were
investigated by a single dose triple cross over method in
sheep following intravenous administration of three
different doses.
Sampling Procedure
Blood samples were collected in heparinized
centrifuge tubes 0.5, 1.0, 2.0, 4.0, 8.0, 12.0 and 24.0
hours after drug administration. Immediately after
collection, the blood samples were centrifuged at 2000,
rpm for 10 minutes plasma was separated and used fresh
for the drug analysis.
Drug Analysis
The concentrations of oxytetracycline in plasma
samples was measured by disc agar diffusion bioassay
using Bacillus subtilis as the test organism as described by
Arret et al. (4).
Data Analysis
The pharmacokinetic parameters were estimated
using the nonlinear least square regression technique
employed in PK II-, which is software for
pharmacokinetics analysis (5). An appropriate model was
selected on the basis of the least Akaike Information
Criterion (AIC) values (6).
The parameters included the peak plasma
concentration (Cmax), area under the plasma
concentration-time curve (AUC0-∞), first moment of
plasma concentration time curve (AUMC0-∞), mean
residence time (MRT) and distribution half-life (t1/2α),
elimination half-life (t1/2 elim), apparent volume of
distribution (Vd) and total body clearance (Clt).
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Results and Discussion
There was no dropout of animals during the study.
The mean±SEM for the plasma concentration of
oxytetracycline after intravenous administration of 40,
80 and 160 mg/kg in sheep are given in Table 1. The
average plasma concentrations of the drug against time
are plotted in Fig. 1. The data was best fitted by the two
compartment open model as mentioned by the lowest AIK
values in each case. The previous studies on the
pharmacokinetics of oxytetracycline have also been
described by the two compartment open model (8-9).
The increase in the concentration of oxytetracycline was
shown with increasing dosage at all the sampling times in
sheep. This increase in concentration seems to be dose
dependent.
The mean±SEM for the intravenous pharmacokinetic
parameters based on the plasma level-time profile of the
drug are presented in Table 2. After the administration of
a single dose of oxytetracycline at the rate of 40, 80 and
160 mg/kg body weight, the drug attained the maximum
plasma concentrations Cmax of 18.67±0.095,
40.63±0.16 and 85.51±0.10 µg/ml, respectively. In
healthy pigs, George and coworkers (10) reported Cmax
values of 73 µg/ml after a single intramuscular dose of 20
mg/kg which is comparable with the Cmax values
originated after administration of 40 mg/kg dose in the
present study. It is far higher than the reported Cmax value
of 4 µg/ml after the administration of 20 mg/kg dose in
young cattle by Toutain and Raynaud (11). These
variations are due to the differences in dose, routes of
administration and species.
The AUC0-∞ values were noted to be 76.68±0.71,
137.21±0.89 and 237.97±0.80 µg.h/ml after the
administration of intravenous dose of 40, 80 and 160
mg/kg. MRT values of 11.23±0.25 hours after 40 mg/kg
dose reduced to 5.78±0.08 hours after 80 mg/kg dose
while it was 6.73±0.05 hours after an administration of
160 mg/kg dose. Oukessou et al. (12) reported a value of
MRT of 7.7±2.8 hours after an intravenous dose of 5
mg/kg in camels.
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10.88±0.29
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8.19±0.20
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0.25±0.00
5.87±0.08
137.21±0.89
794.09±14.25
5.78±0.08
9.73±0.06
5.09±0.16
40.63±0.16

0.31±0.00
7.35±0.06
273.97±0.80
1843.09±12.9
6.73±0.05
9.74±0.03
6.22±0.06
86.51±0.10

The t1/2 elim is the time required for 50% of the drug
to be eliminated from the body after distribution

Mean±SEM
(n=20)
concentration
of
oxytetracycline
after
administration of various
intravenous doses of 40, 80 &
160 mg/kg body weight.

Figure 1.

Mean plasma concentration of
Oxytetracycline against time
following
intravenous
administration
in
sheep
(n=20).

Table 2.

Mean±SEM
(n=20)
pharmacokinetics parameters
of
oxytetracycline
after
administration of various
intravenous doses of 40, 80 &
160 mg/kg body weight.

40 mg/kg
80 mg/kg
160 mg/kg

INTRAVENOUS DOSES

The t1/2α was observed to be 0.52±0.01, 0.25±0.00
and 0.31±0.00 hours after a dose of 40, 80 & 160
mg/kg body weight. These values are far lower than the
reported value of 2.0 to 2.5 hours after a dose of 20
mg/kg in cows and calves after an intramuscular injection
(13). These differences may be attributed to the variation
in the dosage form, species and route of drug
administration.

Table 1.

equilibrium has been attained. The half-lives of
oxytetracycline
were found to be 10.88±0.29,
5.87±0.08 and 7.35±0.08 after intravenous
administration of the drug at a dosage level of 40, 80 &
160 mg/kg body weight, respectively. In calves, after an
administration of a test preparation of oxytetracycline,
Black and coworkers (14) reported a range of t1/2 elim
to be 8-14 hours. This range is in fair agreement with
that of the present study. In sheep, the same parameter
is reported to be 6.30 hours after an oxytetracycline
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hydrochloride dose of 10 mg/kg (9) while Meijer et al. (8)
reported a very slow terminal elimination phase of 95
hours in veal calves after intravenous administration. In
cattle, after an administration of 20 mg/kg of
oxytetracycline intramuscularly, a higher t1/2 elim value of
21.83 hours was recorded by Toutain and Raynaud (11).
The higher value of elimination half-life has been
attributed to a combination of continued absorption and
elimination of the drug. The elimination half-life after
intravenous and intramuscular administration in buffalo
calves at a dosage level of 22 mg/kg were reported to be
2.82-3.6 h and 10.5-16.5 h, respectively (15). The t1/2
elim value after I/V administration in this previous study
is less than these present values but unexpectedly the
value after I/M administration is similar to those of the
present study.
Total body clearance has been concluded in the
present study to be 8.71±0.08, 9.73±0.06 & 9.74±0.03
ml/h after an administration of 40, 80 & 160 mg/kg
respectively. Reported values of total body clearance after

intravenous and intramuscular dose of 22 mg/kg in
buffalo calves varied from 1.02-1.45 ml/h/kg and 1.171.49 ml/h/kg, respectively (15). There was higher Clt
value of 75.3±23.2 ml/h/kg after 5 mg/kg in camels and
281 ml/h/kg in sheep after intravenous administration of
10 mg/kg of oxytetracycline hydrochloride (9, 12). In the
present study, the volume of distribution was determined
to be 8.19±0.20, 5.09±0.16 and 6.22±0.06 liters after
administration of 40, 80 and 160 mg/kg body weight of
oxytetracycline, respectively. Varma and Paul (15)
reported a value of Vd to be 1.18-2.15 l/kg in buffalo
calves after an intramuscular dose of 22 mg/kg body
weight. An intravenous dose of 5 mg/kg body weight in
camels generated a Vd value of 706.00±168.6 ml/kg
(12).
In comparison with the different intravenous doses of
oxytetracycline in the present study, the plasma levels of
the drug seems to be dose dependent. The experimental
validation and effect of diseased conditions must be
analyzed.
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